Aortic valve treatment: from the first aortic valve replacement to the last decade of revolution

Paradies, Valeria; Mamas, Mamas A

Abstract

The first aortic valve replacement (AVR) from a human patient performed in 1962 marked the beginning of an evidence-based journey of open-heart surgery for aortic valve stenosis (AVS). Surgical aortic valve replacement (SAVR) has long been the standard treatment to reduce symptoms and improve survival in patients with severe AVS through multiple trials, with an established durability beyond 10 years and low mortality rate in the absence of serious comorbidities.1 Nevertheless, over the last two decades, we have witnessed a rapidly evolving evidence basis for the treatment of AVS since the first human transcatheter aortic valve implantation (TAVI) by Alain Cribier in 2002.

Citation

Paradies, V., & Mamas, M. A. (2022). Aortic valve treatment: from the first aortic valve replacement to the last decade of revolution. Heart, heartjnl-2022-321933. https://doi.org/10.1136/heartjnl-2022-321933

• Journal Article Type: Editorial
• Acceptance Date: Dec 5, 2022
• Online Publication Date: Mar 10, 2023
• Publication Date: Dec 5, 2022
• Deposit Date: Jun 20, 2023
• Journal: Heart
• Print ISSN: 1355-6037
• Electronic ISSN: 1468-201X
• Publisher: BMJ Publishing Group
• Peer Reviewed: Peer Reviewed
• Pages: heartjnl-2022-321933
• DOI: https://doi.org/10.1136/heartjnl-2022-321933
• Keywords: Cardiology and Cardiovascular Medicine